Hematology clinical research training program

血液学临床研究培训计划(T32 HL-07439)PI：Brass，Lawrence F. 项目总结 宾夕法尼亚大学血液学临床研究培训计划于#年建立。 1978年，为162名男性和女性提供了基础和翻译研究培训。该计划的 主要目标是帮助不同的个人群体为成为广泛定义的 血液学和血液病学科。教职员工包括39名各级教员和一项计划 在适当的情况下，是否可以增加或取消培训人员。每年最多招收12名新学员 (博士后8人，博士后4人)。候选人最初主要是从参加 内科和儿科的临床血液学培训计划。自1998年以来，我们还 支持不是医生的博士后实习生，自2004年以来，支持博士后实习生，其中许多人 参加了宾夕法尼亚大学的医学博士项目。监督来自我们的内部监督委员会和我们的 外部咨询委员会。与MD-PhD项目的联系利用了PI作为 也是那个项目的主管。包括博士前学生反映了我们对长期价值的信念 让有天赋的学生在他们接受科学家培训的早期阶段参与血液学相关研究 以及内科科学家。该计划的基本特点包括正式和非正式的咨询、技能 讲习班、参加地方研讨会和国家会议、课程安排、负责人培训 进行研究，以及由我们的外部咨询参加的年度演示和反馈会议 董事会成员。MD博士后研究员可以选择参加生物医学研究生研究(BGS) 博士学位课程。最近有两位研究员做到了这一点。结果。162名学员(包括目前受聘的学员) 已得到该计划的支持：133名博士后(69名医学博士、24名医学博士和40名博士)和29名博士后(19名在 医学博士学位课程和博士学位课程中的10个)。在完成所有阶段培训的131人中，至少 97人(74%)担任或曾经担任(3人已去世或退休)我们认为合适的职位 此培训计划的校友：50%在学术机构担任全职工作，21%受雇于 生物技术或制药行业，1%在NIH，1%在NIH以外的研究机构，2% 在学术界或美国国立卫生研究院之外提供输血服务。在学术界，76%的人已经或曾经做过研究 来自任何来源的资金，51%已经或曾经得到NIH的支持，HLBI至少是以下方面的支持来源 一半。一项详细的计划，吸引和培训不同的男女群体，监测他们的进展 以个性化发展计划为基准，并从学员、校友和 教师也包括在申请中。要求在目前的水平上重新提供资金。

Hematology Clinical Research Training Program (T32 HL-07439) PI: Brass, Lawrence F. PROJECT SUMMARY The Hematology Clinical Research Training Program at the University of Pennsylvania was established in 1978 and has provided basic and translational research training for 162 men and women. The program’s primary goal is to help a diverse group of individuals prepare for careers as investigators in the broadly-defined discipline of hematology and blood disorders. The faculty includes 39 trainers of all academic ranks and a plan is in place for adding or withdrawing trainers when appropriate. Up to 12 new trainees are accepted each year (8 postdocs and 4 predocs). Candidates were originally were drawn primarily from physicians enrolled in the clinical hematology training programs in the Departments of Medicine and Pediatrics. Since 1998 we have also supported postdoctoral trainees who are not physicians and, since 2004, predoctoral trainees, many of whom have been in Penn’s MD-PhD program. Oversight comes from our internal Oversight Committee and our External Advisory Board. The connection to the MD-PhD program takes advantage of the PI’s role as the director of that program as well. The inclusion of predoctoral students reflects our belief in the long term value of involving talented students to hematology-related research at an earlier point in their training as scientists and physician-scientists. Essential features of the program include formal and informal advising, skills workshops, attendance at local seminars and national conferences, coursework, training in the responsible conduct of research, and an annual presentation and feedback session attended by our external advisory board members. MD postdoctoral fellows have the option of enrolling in a Biomedical Graduate Studies (BGS) PhD program. Two recent fellows have done so. Outcomes. 162 trainees (including those currently appointed) have been supported by this program: 133 postdocs (69 MD, 24 MD-PhD and 40 PhD) and 29 predocs (19 in the MD-PhD program and 10 in a PhD program). Of the 131 who have completed all stages of training, at least 97 (74%) hold or have held (3 are deceased or retired) positions that we consider appropriate outcomes for alumni of this training program: 50% with full-time appointments at an academic institution, 21% employed in the biotech or pharmaceutical industries, 1% at the NIH, 1% at a research institute other than the NIH, and 2% who run transfusion services outside of academia or the NIH. Of those in academia, 76% have or had research funding from any source and 51% have or had NIH support, with HLBI being the source of support for at least half. A detailed plan for attracting and training a diverse group of men and women, monitoring their progress benchmarked with an individualized development plan, and receiving feedback from trainees, alumni and faculty is included in the application. Renewed funding is requested at the present level.